Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
leadXpro specializes in structure-based drug discovery focused on challenging membrane protein targets. The company provides contract research services to pharma, biotech, and academic partners at all stages of early drug discovery. It leverages advanced structural biology platforms—including cryo-electron microscopy—and computational tools to accelerate hit finding and optimization. Recent collaborations include developing modulators of the GPCR target GPR65 for neurodegenerative disease therapy. No proprietary clinical results or late-stage programs are publicly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on leadXpro.